nih-gov/www.ncbi.nlm.nih.gov/books/NBK548812/index.html?report=printable

150 lines
No EOL
17 KiB
XML

<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- AppResources meta begin -->
<meta name="paf-app-resources" content="" />
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<!-- AppResources meta end -->
<!-- TemplateResources meta begin -->
<meta name="paf_template" content="" />
<!-- TemplateResources meta end -->
<!-- Logger begin -->
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548812" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548812/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
<!-- Logger end -->
<title>Antihypertensive Agents - LiverTox - NCBI Bookshelf</title>
<!-- AppResources external_resources begin -->
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
<!-- AppResources external_resources end -->
<!-- Page meta begin -->
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Antihypertensive Agents" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2017/07/20" /><meta name="citation_pmid" content="31644119" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548812/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Antihypertensive Agents" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2017/07/20" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548812/" /><meta name="description" content="Antihypertensive medications are some of the most important and commonly used drugs in medical practice. Hypertension affects at least 50% of persons over the age of 60 and is an important cause of morbidity and mortality from cardiovascular and cerebrovascular disease." /><meta name="og:title" content="Antihypertensive Agents" /><meta name="og:type" content="book" /><meta name="og:description" content="Antihypertensive medications are some of the most important and commonly used drugs in medical practice. Hypertension affects at least 50% of persons over the age of 60 and is an important cause of morbidity and mortality from cardiovascular and cerebrovascular disease." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548812/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/AntihypertensiveAgen/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548812/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
<!-- Page meta end -->
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D1A397D7B6E610000000000850075.m_5" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
<body class="book-part">
<div class="grid no_max_width">
<div class="col twelve_col nomargin shadow">
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
<div class="sysmessages">
<noscript>
<p class="nojs">
<strong>Warning:</strong>
The NCBI web site requires JavaScript to function.
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
</p>
</noscript>
</div>
<!--/.sysmessage-->
<div class="wrap">
<div class="page">
<div class="top">
<div class="header">
</div>
<!--<component id="Page" label="headcontent"/>-->
</div>
<div class="content">
<!-- site messages -->
<div class="container content">
<div class="document">
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div></div></div>
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548812_"><span class="title" itemprop="name">Antihypertensive Agents</span></h1><p class="small">Last Update: <span itemprop="dateModified">July 20, 2017</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="AntihypertensiveAgen.OVERVIEW"><h2 id="_AntihypertensiveAgen_OVERVIEW_">OVERVIEW</h2><p>Antihypertensive medications are some of the most important and commonly used drugs in medical practice. Hypertension affects at least 50% of persons over the age of 60 and is an important cause of morbidity and mortality from cardiovascular and cerebrovascular disease.</p><p>More than 50 medications are used in the therapy of hypertension. The drugs can be categorized into seven major classes: (1) diuretics, (2) sympatholytic drugs, (3) calcium channel blockers, (4) angiotensin converting enzyme [ACE] inhibitors, (5) angiotensin II receptor antagonists/blockers [ARBs], (6) direct renin antagonists, and (7) various vasodilators.</p><p>Overall, the antihypertensive agents are rare causes of drug induced liver injury, the exceptions being two agents that have been in use for more than 50 years and are now not commonly used: methyldopa and hydralazine. The other antihypertensive drugs have been linked to drug induced liver injury only in isolated case reports and are rarely listed in large case series of acute liver failure or clinically apparent liver injury with jaundice due to medications.</p><p>The diuretics can be categorized into four groups: thiazides, loop diuretics, potassium-sparing diuretics, and carbonic anhydrase inhibitors. Some of these agents have been implicated in causing liver injury in rare single case reports.</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">
<a href="/books/n/livertox/ThiazideDiuretics/">Thiazide Diuretics</a>
</p></dd><dt>2.</dt><dd><p class="no_top_margin">
<a href="/books/n/livertox/LoopDiuretics/">Loop Diuretics</a>
</p></dd><dt>3.</dt><dd><p class="no_top_margin">
<a href="/books/n/livertox/Amiloride/">Potassium-Sparing Diuretics</a>
</p></dd><dt>4.</dt><dd><p class="no_top_margin">
<a href="/books/n/livertox/CarbonicAnhydraseInh/">Carbonic Anhydrase Inhibitors</a>
</p></dd></dl><p>Sympatholytic drugs include alpha- and beta-adrenergic receptor antagonists (alpha blockers and beta blockers) as well as centrally acting agents such as clonidine, guanabenz, methyldopa, minoxidil, and reserpine. These agents rarely cause liver injury, the exception being methyldopa which can cause acute or chronic hepatitis, that can be severe, resulting in acute liver failure or cirrhosis.</p><ul class="simple-list"><li class="half_rhythm"><div>
<a href="/books/n/livertox/AlphaBlockers/">Alpha Adrenergic Receptor Antagonists</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/Betablockers/">Beta Adrenergic Receptor Antagonists</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/Clonidine/">Clonidine</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/Methyldopa/">Methyldopa</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/Reserpine/">Reserpine</a>
</div></li></ul><p>Calcium channel blockers (CCBs), angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and direct renin inhibitors are some of the most potent and well tolerated antihypertensive agents and are widely used. Many of these agents have been implicated in causing clinically apparent liver injury, but only in isolated case reports.</p><ul class="simple-list"><li class="half_rhythm"><div>
<a href="/books/n/livertox/Aliskiren/">Aliskiren</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/ACEinibitors/">Angiotensin-Converting Enzyme Inhibitors</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/ARBs/">Angiotensin II Receptor Antagonists</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/CalciumChannelBlocke/">Calcium Channel Blockers</a>
</div></li></ul><p>Finally, various arterial and venous vasodilators are useful for managing hypertension in special situations. Guanfacine, minoxidil and nitroprusside have not been implicated in causing liver injury. In contrast, hydralazine is a well known cause of clinically apparent liver injury, often presenting with autoimmune features.</p><ul class="simple-list"><li class="half_rhythm"><div>
<a href="/books/n/livertox/Guanfacine/">Guanfacine</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/Hydralazine/">Hydralazine</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/Minoxidil/">Minoxidil</a>
</div></li><li class="half_rhythm"><div>
<a href="/books/n/livertox/Nitroprusside/">Sodium Nitroprusside</a>
</div></li></ul><p>Heart Failure Agent</p><ul class="simple-list"><li class="half_rhythm"><div>
<a href="/books/n/livertox/Sacubitril/">Sacubitril-Valsartan</a>
</div></li></ul></div><div id="AntihypertensiveAgen.ANNOTATED_BIBLIOGRA"><h2 id="_AntihypertensiveAgen_ANNOTATED_BIBLIOGRA_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 20 July 2017</p><ul class="first-line-outdent"><li><div class="bk_ref" id="AntihypertensiveAgen.REF.zimmerman.1999">Zimmerman HJ. Antihypertensive agents. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd edition. Philadelphia: Lippincott Williams &#x00026; Wilkins, 1999. p. 654-60.<div><i>(Expert review of drug induced liver injury due to antihypertensive agents published in 1999 discusses captopril, hydralazine and methyldopa).</i></div></div></li><li><div class="bk_ref" id="AntihypertensiveAgen.REF.de_marzio.2013">De Marzio DH, Navarro VJ. Antihypertensives. Hepatotoxicity of cardiovascular and antidiabetic drugs: antihypertensives. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, pp. 522-5.<div><i>(Review of hepatotoxicity of antihypertensive agents discusses hydralazine, diuretics, ACE inhibitors, ARBs, beta blockers, calcium channel blockers and methyldopa).</i></div></div></li><li><div class="bk_ref" id="AntihypertensiveAgen.REF.michel.2011">Michel T, Hoffman BB. Treatment of myocardial ischemia and hypertension. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman&#x02019;s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 745-88.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="AntihypertensiveAgen.REF4"><span class="ref-title">Drugs for hypertension.</span>
<span class="ref-journal">Treat Guidel Med Lett</span>
2014; 12 (141): 31-8.
[<a href="https://pubmed.ncbi.nlm.nih.gov/24759265" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24759265</span></a>]<div><i>(Concise summary recommendations for treatment of hypertension and current understanding of indications, efficacy and safety).</i></div></div></li><li><div class="bk_ref" id="AntihypertensiveAgen.REF5"><span class="ref-title">Drugs for hypertension.</span>
<span class="ref-journal">Med Lett Drugs Ther</span>
2017; 59 (1516): 41-8.
[<a href="https://pubmed.ncbi.nlm.nih.gov/28263286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28263286</span></a>]<div><i>(Concise summary recommendations for treatment of hypertension and current understanding of indications, efficacy and safety).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548812</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31644119" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31644119</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Antihistamines/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Antiinfective/" title="Next page in this title">Next &gt;</a></div></div></div></div>
</div>
</div>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
<component id="Breadcrumbs" label="helpdesk"/>-->
</div>
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
</div>
</div>
<!--/.page-->
</div>
<!--/.wrap-->
</div><!-- /.twelve_col -->
</div>
<!-- /.grid -->
<span class="PAFAppResources"></span>
<!-- BESelector tab -->
<noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548812&amp;ncbi_domain=livertox&amp;ncbi_report=printable&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548812/?report=printable&amp;ncbi_app=bookshelf" /></noscript>
<!-- usually for JS scripts at page bottom -->
<!--<component id="PageFixtures" label="styles"></component>-->
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal106 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
</html>